Pfizer stock price prediction for 2026, 2030, 2035, 2040, 2045, and 2050 focuses on Pfizer, a global pharmaceutical company operating in the healthcare and medicine industry. The company is known for developing, manufacturing, and selling a wide range of drugs, vaccines, and healthcare products used by patients in numerous countries. Pfizer operates in the research-driven pharmaceutical space and serves hospitals, clinics, pharmacies, and healthcare providers worldwide. Its business is based on innovation, large-scale production, and global distribution, making it one of the most recognizable names in the international healthcare market with a strong presence in many regions.
Pfizer Fundamentals
Pfizer has a market capitalization of $147.20 billion, representing its total value in the stock market based on current trading prices. The company’s average trading volume is 46.83 million shares, while the latest reported volume is 8.12 thousand shares.
Pfizer offers a dividend yield of 6.64 percent and pays a quarterly dividend of $0.43 per share, with an ex-dividend date of January 23, 2026. The stock is trading at a price-to-earnings ratio of 15.04 and has a 52-week high of $27.69 and a 52-week low of $20.92. Earnings per share are reported at $1.72, the beta value is 0.47, and the total number of outstanding shares is 5.69 billion.
Pfizer Stock Price Prediction 2026
The Pfizer share price target for 2026 is based on the given price range, which indicates how the stock might trade in that particular year. The company operates in the global pharmaceutical sector and maintains its position as a major healthcare provider with a wide range of medical products. For 2026, the expected price movement is projected to be between $20 at the lower end and $30 at the upper end. This means the stock is expected to remain within this range throughout the year, showing potential shifts in market valuation while staying close to its current trading zone.
Pfizer Stock Price Prediction 2030
The Pfizer share price target for 2030 shows a higher trading band compared to previous years, highlighting a broader price range for the stock. As a global pharmaceutical company with a large product portfolio, Pfizer is closely tracked by investors and market participants. For 2030, the stock is expected to trade between $45 and $55, placing it significantly above the levels seen in previous years. This range indicates how the market might value the company during that period, based on its size and presence in the healthcare industry.
Pfizer Stock Price Prediction 2035
The Pfizer share price target for 2035 represents another step forward in the stock’s long-term price outlook. By this time, Pfizer is expected to remain a leading player in the global pharmaceutical sector, catering to a wide range of healthcare needs across different regions. The price band given for 2035 starts at $70 and goes up to $90, indicating a notable increase from the previous target years. This range suggests how the stock value might appreciate over time as the company continues its operations in the global drug and healthcare market.
Pfizer Stock Price Prediction 2040
The Pfizer share price target for 2040 is at a significantly higher level compared to previous targets, reflecting the long-term perspective on the company’s stock value. Pfizer’s role as a global pharmaceutical manufacturer and healthcare solutions provider makes it one of the most recognized names in the industry. For the year 2040, the expected trading range is set between $135 and $175, representing a broad band that captures the potential market valuation during that period. This range reflects the long-term market outlook for a company of Pfizer’s size and global reach.
Pfizer Stock Price Prediction 2045
The Pfizer share price target for 2045 presents a higher price range, indicating another long-term perspective on the stock’s potential market value. As a multinational pharmaceutical company, Pfizer continues to be involved in the research, development, manufacturing, and distribution of medicines and vaccines. The target range for 2045 is set between $220 and $290, showing a significant increase compared to previous years. This range suggests what the stock’s market value could be at that stage, based on its sustained presence in the healthcare sector.
Pfizer Stock Price Prediction 2050
The Pfizer share price target for 2050, as shown in the provided prediction table, represents the furthest outlook and the widest projected price range. Pfizer is expected to remain a major global pharmaceutical company with a strong position in the international healthcare industry. For the year 2050, the stock is projected to trade between $450 and $550, placing it at a significantly higher level than previous targets. This wide range reflects the long-term market view regarding the company’s stock value over several decades.
Pfizer Shareholding
Pfizer’s shareholding structure reveals that insiders hold 0.07 percent of the total shares, representing a very small portion of the company’s ownership. Institutional investors hold the majority stake, with institutions owning 67.50 percent of the total shares, and 67.55 percent of the company’s public float also held by institutional investors. Currently, there are 3,572 institutions holding Pfizer shares, indicating broad participation from large financial organizations and investment firms. This structure suggests that the company is predominantly institutionally owned, with limited insider ownership.
Disclaimer
The information shared on this website is for general informational and educational purposes only. We are not a SEBI-registered firm, and we do not provide any investment, trading, or financial advisory services. Stock market investments are subject to risk, and market conditions can change at any time. Readers are advised to consult a certified financial advisor or conduct their own research before making any investment decisions. We will not be responsible for any profits or losses incurred based on the information provided on this website.
